Should my patients with hypertension be referred for renal denervation?

Should my patients with hypertension be referred for renal denervation? Q:Maybe.Select patients should be referred after informed and shared decision-making.Patients with treatment-resistant hypertension or intolerance to further medication adjustments may be suitable candidates for renal denervation, as it demonstrates a blood pressure (BP)-lowering effect of 5 to 7 mm Hg, comparable to the effect of adding another antihypertensive agent (Figure 1). [1][2]2][3][4][5] Two renal denervation systems-ultrasound and radiofrequency based-are currently approved by the US Food and Drug Administration. 6,7The European Society of Hypertension updated guidelines 8 state that renal denervation is a consideration for true treatmentresistant hypertension and for patients with drug intolerances and an estimated glomerular fi ltration rate (eGFR) greater than 40 mL/minute/1.73m 2 .

Authors

Institutions

Publication Details

Journal
Cleveland Clinic Journal of Medicine
Published
2024-09-01
DOI
https://doi.org/10.3949/ccjm.91a.24029
Citations
1
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Should my patients with hypertension be referred for renal denervation?

Khaled M. Ziada, Ali Mehdi, Elias Bassil, Luke J. Laffin et al.
1 citations
Cleveland Clinic Journal of Medicine
Blood Pressure and Hypertension Studies
0.40
article

Should my patients with hypertension be referred for renal denervation?

Khaled M. Ziada, Ali Mehdi, Elias Bassil, Luke J. Laffin, George Thomas, Leen Al-yacoub, Aravinda Nanjundappa
article en
1 citations

Abstract

Should my patients with hypertension be referred for renal denervation? Q:Maybe.Select patients should be referred after informed and shared decision-making.Patients with treatment-resistant hypertension or intolerance to further medication adjustments may be suitable candidates for renal denervation, as it demonstrates a blood pressure (BP)-lowering effect of 5 to 7 mm Hg, comparable to the effect of adding another antihypertensive agent (Figure 1). [1][2]2][3][4][5] Two renal denervation systems-ultrasound and radiofrequency based-are currently approved by the US Food and Drug Administration. 6,7The European Society of Hypertension updated guidelines 8 state that renal denervation is a consideration for true treatmentresistant hypertension and for patients with drug intolerances and an estimated glomerular fi ltration rate (eGFR) greater than 40 mL/minute/1.73m 2 .

Cleveland Clinic Journal of MedicineVol. 91(9)
Cleveland Clinic (US), Cleveland Clinic Lerner College of Medicine (US), Case Western Reserve University (US)
Zero hunger
Openalex Percentile: Top 33%
Blood Pressure and Hypertension Studies
0.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.